Nuclease Probe Technologies is Biotechnology in United States that focus on developer business. Founded in 2014. They cover business area such as developer, rapid diagnostic assay, disease-associate nuclease activity, rapid pathogen identification, patient, bloodstream infection, a process, phenotypic antibiotic susceptibility testing, ast, unnecessary delay, treatment.
2014
( 10 years old in 2024 )
Developer
-
110 Canal Street, 4th Floor
C/O M2D2
Lowell, MA 01852
United States
Private
developerrapid diagnostic assaydisease-associate nuclease activityrapid pathogen identificationpatientbloodstream infectiona processphenotypic antibiotic susceptibility testingastunnecessary delaytreatment
* We use standard office opening hours in near Nuclease Probe Technologies's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Nuclease Probe Technologies is Biotechnology business from United States that founded in 2014 (10 years old in 2024), Nuclease Probe Technologies business is focusing on Developer.
Nuclease Probe Technologies headquarter office and corporate office address is located in 110 Canal Street, 4th Floor C/O M2D2 Lowell, MA 01852 United States.
Nuclease Probe Technologies was founded in United States.
In 2024, Nuclease Probe Technologies is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Nuclease Probe Technologies, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
